CNV arrays

Using CNV profiles for more than 40,000 individuals with or without schizophrenia, researchers got a refined look at gains and losses linked to the condition.

An analysis focused on large, rare de novo CNVs has identified copy number changes contributing to conotruncal heart disease in Chinese individuals.

Independent analyses on dozens of tumor-normal Sézary syndrome pairs points to frequent alterations in signaling, cell cycle, and epigenetic pathways.

NEW YORK (GenomeWeb News) – An array-based analysis by researchers from Australia and elsewhere has identified a gene that is often missing in ovarian cancers that become resistant to liposomal doxorubicin chemotherapy, hinting that it may serve as a marker for such acquired resistance.

By Molika Ashford
Advocacy group Autism Speaks has announced a partnership with Chinese genomics institute BGI to sequence the whole genomes of 10,000 individuals in families of children with autism spectrum disorder.

Independent research groups have used array and sequencing-based approaches to catalog CNVs in three Asian populations and gain insights into CNV breakpoint patterns in three individuals.

After looking for associations between common CNVs and eight common diseases in more than 16,000 affected individuals, members of the Wellcome Trust Case Control Consortium concluded that these CNVs aren't major players in these diseases.

Using array-based methods, researchers have mapped almost 12,000 potential copy number variants in the human genome and developed reference genotypes for almost 5,000 CNVs.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.